FindTrial
Sign In

Role of Vitamin B12 levels in evaluating the disease outcome among patients with sepsis

Vitamin B12 levels as a cryptic biomarker in evaluating the outcome among patients with sepsis - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/10/058838
Enrollment
30
Registered
2023-10-18
Start date
Unknown
Completion date
Unknown
Last updated
2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: A419- Sepsis, unspecified organism

Interventions

Intervention1: Nil: Nil Control Intervention1: Nil: Nil

Sponsors

Indian Council of Medical Research (ICMR) - Short Term Studentship (STS)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Newly diagnosed patients with sepsis (according to Sepsis-3 criteria) >18 years, admitted in the medical ICU 2. Those providing informed consent to participate in the study

Exclusion criteria

Exclusion criteria: 1. Pregnant females 2. Diagnosed patients of cancers, hepatic dysfunction, severe malnutrition, immunodeficiency disorders 3. Known patients having hematological diseases 4. Patients on steroid therapy

Design outcomes

Primary

MeasureTime frame
Association the between Serum Vitamin B12 levels and 28-day mortality in patients having sepsis Timepoint: 4 weeks—

Secondary

MeasureTime frame
Association between serum folic acid levels & albumin-to-fibrinogen ratio, & 28-day mortality in patients with sepsis compared to other sepsis markers.Timepoint: 4 weeks—

Countries

India

Contacts

Public ContactKanika Yadav

Kasturba Medical College, Manipal

mm.prabhu@manipal.edu9449592986

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026